3Escher N, Spies-Weisshart B, Kaatz C, et al. Identification of HNP3 as a tumor marker in CD4^+ and CD4^- lymphocytes of patients with cutaneous T-cell lymphoma[J]. Eur J Cancer,2006,42(2):249-255.
4Miguet L, Bogumil R, Decloquement P, et al. Discovery and identification of potential biomarkers in prospective study of chronic lymphoid malignancies using SELDI-TOF- MS[ J ]. J Proteome Res, 2006,5 (9) : 2258-2269.
5Srinivasan R, Daniels J, Fusaro V, et al. Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis [ J ]. Exp Hematol, 2006,34(6) : 796-801.
6Imanguli MM, Atkinson JC, Harvey KE, et al. Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation[J]. Exp Hematol,2007,35(2) : 184-192.
7Hayman MW, Przyborski SA. Proteomic idenfication of biomarkers expressed by human pluripotent stem cells [ J ]. Biochem Biophys Res Commun,2004,316(3) :918-923.
8Svensson AM, Whiteley GR, Callas PW, et al. SELDI-TOF plasma profiles distinguish individuals in a protein C-deficient family with thrombotic episodes occurring before age 40[J]. Thromb Haemost,2006,96 (6) :725-730.
9Issaq HJ, Conrads TP, Prieto DA, et al. SELDI-TOF-MS for diagnostic promteomics[ J]. Anal Chem,2003,75(7) : 148A-155A.
10Kemna E,Tjalsma H, Laarakkers C, et al. Novel urine hepcidin assay by mass spectrometry[ J]. Blood,2005, 106(9) :3268-3270.
